E2F signature is predictive for the pancreatic adenocarcinoma clinical outcome and sensitivity to E2F inhibitors, but not for the response to cytotoxic-based treatments - Concepedia

Concepedia

Publication | Open Access

E2F signature is predictive for the pancreatic adenocarcinoma clinical outcome and sensitivity to E2F inhibitors, but not for the response to cytotoxic-based treatments

DOI Full Paper Access

35

Citations

35

References

2018

Year

Wenjun Lan, Benjamin Bian, Yi Xia, Samir Dou, Odile Gayet, Martin Bigonnet, Patricia Santofimia‐Castaño, Mei Cong, Ling Peng, Nelson Dusetti,

Scientific Reports

References

	Year	Citations

Page 1